Flash FinanceUS
Market closed S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · InspireMD, Inc. (NSPR)

InspireMD Q2 2026 net loss widens to $14.3 million as recall weighs on revenue

Negative Impact 4 of 5 earnings Written later

InspireMD reported second quarter 2026 revenue of $1.8 million, flat year over year, with a gross loss of $774,000 after a U.S. recall of the CGuard Prime 135 cm delivery system. The net loss was $14.3 million, or $0.17 per share, compared with $13.2 million, or $0.26 per share, a year earlier, and cash and marketable securities fell to $30.4 million by June 30, 2026.

Key points

  • Q2 2026 total revenue was $1,771,000, down 0.4% from $1,778,000; international revenue rose 21% to $2,122,000 while U.S. revenue was negative at $(351,000) due to $734,000 of recall customer credits.
  • Q2 2026 net loss was $14,324,000, or $0.17 per share, versus $13,151,000, or $0.26 per share, in Q2 2025.
  • Cash and cash equivalents and marketable securities were $30,421,000 at June 30, 2026, compared with $54,211,000 at December 31, 2025.
  • The company said it initiated cost-saving actions after the quarter ended, expected to generate annual savings of approximately $9 million.

The filing

CompanyInspireMD, Inc. (NSPR)
Form8-K, current report
Filed with the SECAug 17, 2026, 7:05 AM ET
Accession number0001493152-26-038624

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 10:08 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on August 17, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.